Article Details
Retrieved on: 2022-10-14 15:20:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the appointment of ...
Article found on: investchronicle.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here